Literature DB >> 3829584

Influence of tobacco abstinence on the disposition kinetics and effects of nicotine.

B L Lee, N L Benowitz, P Jacob.   

Abstract

Habitual tobacco smoking accelerates the metabolism of many drugs. With tobacco abstinence, it was expected that nicotine metabolism would be slower than when smoking. To test this hypothesis, the disposition kinetics of intravenous nicotine were studied in 20 healthy smokers while smoking, after abstaining from smoking for 1 week, and (in six subjects) when smoking again. Cardiovascular responses to nicotine were also measured. Unexpectedly, total and nonrenal clearance of nicotine increased by 36% and 39%, respectively, during abstinence. The increase in clearance after brief abstinence suggests that nicotine or its metabolites or another component of cigarette smoke inhibits nicotine metabolism in smokers. Cardiovascular responses to nicotine were greater after 1 week compared with overnight abstinence, consistent with loss of tolerance.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3829584     DOI: 10.1038/clpt.1987.59

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  18 in total

1.  Lack of effect of short-term passive smoking on the metabolic disposition of theophylline.

Authors:  D T Casto; B M Schnapf; M A Clotz
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

2.  Persistent decrease in heart rate after smoking cessation: a 1-year follow-up study.

Authors:  A M Persico
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

3.  Evidence of transient heart rate change after smoking cessation.

Authors:  K D Ward; A J Garvey; R E Bliss
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

4.  Acute changes in forearm haemodynamics produced by cigarette smoking in healthy normotensive non-smokers are not influenced by propranolol or pindolol.

Authors:  P Brunel; X Girerd; S Laurent; B Pannier; M Safar
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

5.  Blood flow velocity in the extraocular vessels in chronic smokers.

Authors:  H J Kaiser; A Schoetzau; J Flammer
Journal:  Br J Ophthalmol       Date:  1997-02       Impact factor: 4.638

6.  Bioavailability and absorption kinetics of nicotine following application of a transdermal system.

Authors:  S K Gupta; N L Benowitz; P Jacob; C N Rolf; J Gorsline
Journal:  Br J Clin Pharmacol       Date:  1993-09       Impact factor: 4.335

7.  Chronic and acute tolerance to the heart rate effects of nicotine.

Authors:  K A Perkins; L H Epstein; R L Stiller; B L Marks; R G Jacob
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

Review 8.  Nicotine chemistry, metabolism, kinetics and biomarkers.

Authors:  Neal L Benowitz; Janne Hukkanen; Peyton Jacob
Journal:  Handb Exp Pharmacol       Date:  2009

9.  Apparent tolerance to the acute effect of nicotine results in part from distribution kinetics.

Authors:  H C Porchet; N L Benowitz; L B Sheiner; J R Copeland
Journal:  J Clin Invest       Date:  1987-11       Impact factor: 14.808

10.  Nicotine self-administration in mice is associated with rates of nicotine inactivation by CYP2A5.

Authors:  Eric C K Siu; Dieter B Wildenauer; Rachel F Tyndale
Journal:  Psychopharmacology (Berl)       Date:  2006-01-28       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.